Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily LLY Bear 1X Shares

17.19
-0.6326-3.55%
Post-market: 16.64-0.5450-3.17%19:40 EST
Volume:12.59K
Turnover:218.36K
Market Cap:2.58M
PE:- -
High:17.49
Open:17.31
Low:17.15
Close:17.82
52wk High:31.30
52wk Low:16.40
Shares:150.00K
Float Shares:150.00K
Volume Ratio:0.37
T/O Rate:8.39%
Dividend:1.01
Dividend Rate:5.88%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Bristol Gate Capital Partners Trims Eli Lilly Stake

TIPRANKS
·
1 hour ago

INNOVENT BIO Shares Surge Over 4% on Strategic Collaboration with Eli Lilly Potentially Worth $8.85 Billion

Stock News
·
2 hours ago

Eli Lilly Earnings Call Highlights Hyper-Growth Momentum

TIPRANKS
·
4 hours ago

BREAKINGVIEWS-The Week in Breakingviews: Shooting for the moon

Reuters
·
4 hours ago

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Canopy Growth (CGC)

TIPRANKS
·
11 hours ago

Innovent Biologics announces collaboration with Lilly

TIPRANKS
·
Yesterday

INNOVENT BIO and Eli Lilly Form Global Strategic Alliance to Advance Oncology and Immunology Drug Development

Stock News
·
Yesterday

BRIEF-Eli Lilly Spokesperson Says No One Should Be Mass-Compounding Or Selling Knockoff Glp-1 Products Regardless Of How They’re Administered

Reuters
·
Yesterday

Eli Lilly Sokesperson: Look Forward to Decisive Steps FDA Has Announced It Will Take, and We Urge Other Regulators and Law Enforcement to Do the Same

THOMSON REUTERS
·
Yesterday

CORRECTED-Weight-loss drugs to compete on biggest stage with Super Bowl ads

Reuters
·
Feb 07

The Weight-Loss Price Wars Are Breaking Big Pharma's Business Model -- Heard on the Street -- WSJ

Dow Jones
·
Feb 07

TrumpRx Is Here. Most People Won't Benefit. -- Barrons.com

Dow Jones
·
Feb 07

Hims & Hers stock nears one-year low amid battle over compounded Wegovy pill

Dow Jones
·
Feb 07

CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder

Benzinga_recent_news
·
Feb 07

Novo Stock Jumps, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle. -- Barrons.com

Dow Jones
·
Feb 06

Novo Nordisk shares rebound as FDA targets illegal drug copies

Reuters
·
Feb 06

FDA Vows Crackdown on Unapproved Weight-Loss Drug Copies, Boosting Shares of Novo Nordisk and Eli Lilly

Stock News
·
Feb 06

GRAPHIC-US equity fund inflows ease as tech selloff weighs

Reuters
·
Feb 06

CORRECTED-CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists (February 5)

Reuters
·
Feb 06